133 related articles for article (PubMed ID: 2614505)
21. Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.
Jones RN; Barry AL
J Clin Microbiol; 1987 Oct; 25(10):1920-5. PubMed ID: 3117843
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
Mortensen JE; LaRocco M; Himes SL; Inderlied C; Daly JA; Campos JM; Mendelman PM
Diagn Microbiol Infect Dis; 1990; 13(4):341-4. PubMed ID: 2076596
[TBL] [Abstract][Full Text] [Related]
23. Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci.
Patterson JE; Farrel P; Zervos MJ
Diagn Microbiol Infect Dis; 1991; 14(6):495-9. PubMed ID: 1802536
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of Haemophilus influenzae type b to ampicillin-sulbactam.
Azimi PH; Dunphy MG
Antimicrob Agents Chemother; 1989 Sep; 33(9):1620-1. PubMed ID: 2817860
[TBL] [Abstract][Full Text] [Related]
25. Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
Firsov AA; Saverino D; Ruble M; Gilbert D; Manzano B; Medeiros AA; Zinner SH
Antimicrob Agents Chemother; 1996 Mar; 40(3):734-8. PubMed ID: 8851602
[TBL] [Abstract][Full Text] [Related]
26. Bacteriological studies with ampicillin/sulbactam on selected strains of gram-negative bacteria.
Bello H; del Solar E; González C; Garcia A; Urrea R; Zemelman R
Diagn Microbiol Infect Dis; 1988 Oct; 11(2):109-15. PubMed ID: 3067960
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
Heizmann W; Heilmann F; Werner H
Infection; 1987; 15(5):370-4. PubMed ID: 3692611
[TBL] [Abstract][Full Text] [Related]
29. Beta-lactamase production and the role of ampicillin/sulbactam.
Alpuche-Aranda CM
Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
[No Abstract] [Full Text] [Related]
30. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
Werner H; Heizmann W; Heilmann F
Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
[TBL] [Abstract][Full Text] [Related]
31. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
Wexler HM; Harris B; Carter WT; Finegold SM
Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
[TBL] [Abstract][Full Text] [Related]
32. Patterns of resistance to anaerobic organisms in Australia.
Munro R
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):159S-163S. PubMed ID: 2591175
[TBL] [Abstract][Full Text] [Related]
33. Escherichia coli resistant to ampicillin/sulbactam.
Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
[TBL] [Abstract][Full Text] [Related]
34. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Sanders CV; Aldridge KE
J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
Pfaller MA; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
[TBL] [Abstract][Full Text] [Related]
36. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Rezvan SP; Sidorenko SV; Budanov SV
Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
[TBL] [Abstract][Full Text] [Related]
37. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
Itokazu GS; Danziger LH
Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624
[TBL] [Abstract][Full Text] [Related]
38. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
Grimm H
Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
[TBL] [Abstract][Full Text] [Related]
39. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
Nord CE
J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
[No Abstract] [Full Text] [Related]
40. [Comparative in vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antibiotics with respect to staphylococci and pneumococci].
Sidorenko SV; Rezvan SP; Speranskaia ON; Tikhonova As; Navashin SM; Ansolis LE; Tsvigun EA; Kuleshov SE; Budanov SV
Antibiot Khimioter; 1995 Mar; 40(3):22-7. PubMed ID: 7575010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
